Brian Wright

In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on Centene (NYSE: CNC) with a Buy rating and $87.00 price target. In the report, Sterne Agee noted, “Centene has become the premier Medicaid pure-play and deserving of its premium multiple to the group. Plus we expect...